Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung: a phase II study.

…, M Veslemes, N Georgatou, D Antoniou… - Anticancer …, 2003 - europepmc.org
Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung:
a phase II study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Bronchial artery embolization in the managment of hemoptysis: A multicenter study in 218 cases

…, S Tassi, M Salomidou, M Nikolopoulou, D Antoniou… - 2012 - Eur Respiratory Soc
AIM: To evaluate the sort and long term results in control of massive and chronic recurrent
hemoptysis in 218 patients with special microspheres (embospheres). MATERIAL AND …

[CITATION][C] Constructing Kannaviou dam

D Antoniou, P Legg, D Glavas - International water power & …, 2004 - pascal-francis.inist.fr
Constructing Kannaviou dam CNRS Inist Pascal-Francis CNRS Pascal and Francis
Bibliographic Databases Simple search Advanced search Search by classification Search …

Management of patients with interstitial lung disease in the midst of the COVID-19 pandemic

KM Antoniou, G Raghu, V Tzilas, D Bouros - Respiration, 2020 - karger.com
Interstitial lung diseases (ILDs) comprise a heterogeneous group of acute and chronic lung
diseases that cause progressive scarring of the lung tissue, compromising respiratory …

[HTML][HTML] Effectiveness of home-based cardiac rehabilitation, using wearable sensors, as a multicomponent, cutting-edge intervention: a systematic review and meta …

V Antoniou, CH Davos, E Kapreli, L Batalik… - Journal of clinical …, 2022 - mdpi.com
Exercise-based cardiac rehabilitation is a highly recommended intervention towards the
advancement of the cardiovascular disease (CVD) patients’ health profile; though with low …

Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis

KM Antoniou, A Pataka, D Bouros… - Pulmonary pharmacology …, 2007 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a poorly understood disease that usually leads to
death within 5 years of diagnosis. Despite our better understanding of IPF pathogenesis, the …

Lung cancer in patients with idiopathic pulmonary fibrosis. A retrospective multicenter study in Greece

…, P Ntolios, R Tringidou, S Papiris, K Antoniou… - Pulmonary …, 2020 - Elsevier
Background Abundant evidence supports an association between Idiopathic Pulmonary
Fibrosis (IPF) and lung cancer development. Data on diagnosis and management of patients …

[HTML][HTML] Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study

K Antoniou, K Markopoulou, A Tzouvelekis… - ERJ open …, 2020 - Eur Respiratory Soc
Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary
fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated …

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis

KM Antoniou, AG Nicholson, M Dimadi… - European …, 2006 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia is a deadly disease with no
effective treatment. The purpose of this randomised prospective multicentric study was to …

Interferons and their application in the diseases of the lung

KM Antoniou, E Ferdoutsis, D Bouros - Chest, 2003 - Elsevier
Interferons (IFNs) are a family of cytokine mediators that are critically involved in alerting the
cellular immune system to viral infections of host cells. There are three major classes of IFNs…